Siis Covovax Approved By Dcgi News

SII’s Covovax approved by DCGI for children aged 7 to 12 years

SII’s Covovax approved by DCGI for children aged 7 to 12 years

New Delhi: On Tuesday, The Serum Institute Of India’s (SII) Covid-19 vaccine Covovax has been approved by the Drugs Controller General of India (DCGI) for children between the age group of 7 and 12 years. The organisation also approved India’s first indigenously developed mRNA vaccine against COVID-19 for restricted use